MedPath

UNIVERSITY OF CINCINNATI

🇺🇸United States
Ownership
-
Established
1819-01-01
Employees
5.9K
Market Cap
-
Website
https://www.uc.edu/

Enhanced Critical Care Air Transport Team Training for Mitigation of Task Saturation

Completed
Conditions
Task Saturation
First Posted Date
2012-06-26
Last Posted Date
2013-03-05
Lead Sponsor
University of Cincinnati
Target Recruit Count
48
Registration Number
NCT01628224
Locations
🇺🇸

University Hospital, Cincinnati, Ohio, United States

Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage

Phase 3
Terminated
Conditions
Subarachnoid Hemorrhage, Aneurysmal
Interventions
First Posted Date
2012-03-28
Last Posted Date
2018-02-01
Lead Sponsor
University of Cincinnati
Target Recruit Count
4
Registration Number
NCT01565590
Locations
🇺🇸

University Hospital, Cincinnati, Ohio, United States

Targeted Intervention for Bipolar Smokers

Not Applicable
Conditions
Nicotine Dependence
Bipolar Disorder
Interventions
Behavioral: Counseling/Managing Mood
Behavioral: Counseling/Healthy Lifestyle
First Posted Date
2012-03-09
Last Posted Date
2014-01-07
Lead Sponsor
University of Cincinnati
Target Recruit Count
50
Registration Number
NCT01550029
Locations
🇺🇸

The University of Cincinnati, Cincinnati, Ohio, United States

Evaluation of Daptomycin for the Emergency Department Treatment of Complicated Skin and Skin Structure Infections

Phase 4
Completed
Conditions
Cellulitis
Skin Infections
Interventions
First Posted Date
2012-03-09
Last Posted Date
2014-08-01
Lead Sponsor
University of Cincinnati
Target Recruit Count
104
Registration Number
NCT01549613
Locations
🇺🇸

University of Cincinnati, Dept. of Emergency Medicine, Cincinnati, Ohio, United States

Evaluating the Role of Immune Responses in the Emergence of Protease Inhibitor Mutations

Completed
Conditions
Hepatitis C
First Posted Date
2012-01-25
Last Posted Date
2015-11-20
Lead Sponsor
University of Cincinnati
Target Recruit Count
10
Registration Number
NCT01517529
Locations
🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

Phase II Axitinib (AG-013736) in Elderly Glioblastoma Multiforme (GBM) Patients

Phase 2
Terminated
Conditions
Glioblastoma Multiforme
Interventions
Radiation: Radiation Therapy
First Posted Date
2012-01-11
Last Posted Date
2017-09-19
Lead Sponsor
University of Cincinnati
Target Recruit Count
1
Registration Number
NCT01508117
Locations
🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

Safety Study of BEZ235 With Everolimus in Subjects With Advanced Solid Tumors

Phase 1
Terminated
Conditions
Cancer
Interventions
First Posted Date
2012-01-11
Last Posted Date
2017-08-23
Lead Sponsor
University of Cincinnati
Target Recruit Count
19
Registration Number
NCT01508104
Locations
🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

Evaluation of the Use of Trental and Vitamin E For Prophylaxis of Radiation Necrosis

Phase 2
Completed
Conditions
Brain Metastasis
Interventions
Dietary Supplement: Vitamin E
First Posted Date
2012-01-11
Last Posted Date
2023-09-14
Lead Sponsor
University of Cincinnati
Target Recruit Count
31
Registration Number
NCT01508221
Locations
🇺🇸

University of Cincinnati, Cincinnati, Ohio, United States

Proteomics & Glyco-Proteomic Analysis of Follicular Fluid

Conditions
Normal Volunteers
Polycystic Ovary Syndrome
Interventions
Drug: IVF Antagonist Protocol
First Posted Date
2011-12-07
Last Posted Date
2011-12-07
Lead Sponsor
University of Cincinnati
Target Recruit Count
30
Registration Number
NCT01487486
Locations
🇺🇸

Center for Reproductive Health, Cincinnati, Ohio, United States

Effects of Omega-3 Fatty Acid Supplementation on Inflammatory Response in Multisystem Trauma Patients

Phase 1
Terminated
Conditions
Multiple Trauma
Interventions
Dietary Supplement: Omega-3
Dietary Supplement: Placebo
First Posted Date
2011-11-22
Last Posted Date
2013-02-25
Lead Sponsor
University of Cincinnati
Target Recruit Count
12
Registration Number
NCT01477697
Locations
🇺🇸

University Hospital, Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath